190 related articles for article (PubMed ID: 34715262)
1. Long-acting injectable donepezil microspheres: Formulation development and evaluation.
Choi GW; Lee S; Kang DW; Kim JH; Kim JH; Cho HY
J Control Release; 2021 Dec; 340():72-86. PubMed ID: 34715262
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic-pharmacodynamic modeling approach for dose prediction of the optimal long-acting injectable formulation of finasteride.
Kang DW; Ryu CH; Kim JH; Choi GW; Kim S; Chon CH; Kim JH; Cho HY
Int J Pharm; 2021 May; 601():120527. PubMed ID: 33781881
[TBL] [Abstract][Full Text] [Related]
3. Three months extended-release microspheres prepared by multi-microchannel microfluidics in beagle dog models.
Kim JH; Ryu CH; Chon CH; Kim S; Lee S; Maharjan R; Kim NA; Jeong SH
Int J Pharm; 2021 Oct; 608():121039. PubMed ID: 34450228
[TBL] [Abstract][Full Text] [Related]
4. Aqueous remote loading of setmelanotide in poly(lactic-co-glycolic acid) microspheres for long-term obesity treatment.
Wang S; Downing G; Olsen KF; Sawyer TK; Cone RD; Schwendeman SP
J Control Release; 2023 Dec; 364():589-600. PubMed ID: 37678438
[TBL] [Abstract][Full Text] [Related]
5. Donepezil accelerates the release of PLGA microparticles via catalyzing the polymer degradation regardless of the end groups and molecular weights.
Quan P; Guo W; LinYang ; Cun D; Yang M
Int J Pharm; 2023 Feb; 632():122566. PubMed ID: 36586633
[TBL] [Abstract][Full Text] [Related]
6. Effects of formulation parameters on encapsulation efficiency and release behavior of risperidone poly(D,L-lactide-co-glycolide) microsphere.
Su Z; Sun F; Shi Y; Jiang C; Meng Q; Teng L; Li Y
Chem Pharm Bull (Tokyo); 2009 Nov; 57(11):1251-6. PubMed ID: 19881277
[TBL] [Abstract][Full Text] [Related]
7. Preparation and evaluation of injectable microsphere formulation for longer sustained release of donepezil.
Ji YB; Lee S; Ju HJ; Kim HE; Noh JH; Choi S; Park K; Lee HB; Kim MS
J Control Release; 2023 Apr; 356():43-58. PubMed ID: 36841288
[TBL] [Abstract][Full Text] [Related]
8. Formulation, characterization, and evaluation of ketorolac tromethamine-loaded biodegradable microspheres.
Sinha VR; Trehan A
Drug Deliv; 2005; 12(3):133-9. PubMed ID: 16025842
[TBL] [Abstract][Full Text] [Related]
9. Controlled drug release from a novel injectable biodegradable microsphere/scaffold composite based on poly(propylene fumarate).
Kempen DH; Lu L; Kim C; Zhu X; Dhert WJ; Currier BL; Yaszemski MJ
J Biomed Mater Res A; 2006 Apr; 77(1):103-11. PubMed ID: 16392139
[TBL] [Abstract][Full Text] [Related]
10. Microsphere delivery of Risperidone as an alternative to combination therapy.
D'Souza S; Faraj J; DeLuca P
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):631-9. PubMed ID: 23892159
[TBL] [Abstract][Full Text] [Related]
11. Particle size studies for subcutaneous delivery of poly(lactide-co-glycolide) microspheres containing ovalbumin as vaccine formulation.
Uchida T; Goto S; Foster TP
J Pharm Pharmacol; 1995 Jul; 47(7):556-60. PubMed ID: 8568620
[TBL] [Abstract][Full Text] [Related]
12. Formulation and in-vitro characterization of retinoic acid loaded poly (lactic-co-glycolic acid) microspheres.
Cirpanli Y; Unlü N; Caliş S; Hincal AA
J Microencapsul; 2005 Dec; 22(8):877-89. PubMed ID: 16423759
[TBL] [Abstract][Full Text] [Related]
13. Effects of formulation factors on encapsulation efficiency and release behaviour in vitro of huperzine A-PLGA microspheres.
Fu X; Ping Q; Gao Y
J Microencapsul; 2005 Feb; 22(1):57-66. PubMed ID: 16019891
[TBL] [Abstract][Full Text] [Related]
14. Effects of formulation factors on encapsulation efficiency and release behaviour in vitro of huperzine A-PLGA microspheres.
Fu X; Ping Q; Gao Y
J Microencapsul; 2005 Nov; 22(7):705-14. PubMed ID: 16421082
[TBL] [Abstract][Full Text] [Related]
15. Preparation and characterization of poly (D,L-lactide-co-glycolide) microspheres for controlled release of poly(L-lysine) complexed plasmid DNA.
Capan Y; Woo BH; Gebrekidan S; Ahmed S; DeLuca PP
Pharm Res; 1999 Apr; 16(4):509-13. PubMed ID: 10227704
[TBL] [Abstract][Full Text] [Related]
16. Preparation and characterization of biodegradable urea-loaded microparticles as an approach for transdermal delivery.
Haddadi A; Farboud ES; Erfan M; Aboofazeli R
J Microencapsul; 2006 Sep; 23(6):698-712. PubMed ID: 17118885
[TBL] [Abstract][Full Text] [Related]
17. Prediction of dexamethasone release from PLGA microspheres prepared with polymer blends using a design of experiment approach.
Gu B; Burgess DJ
Int J Pharm; 2015 Nov; 495(1):393-403. PubMed ID: 26325309
[TBL] [Abstract][Full Text] [Related]
18. Effects of formulation parameters on encapsulation efficiency and release behavior of thienorphine loaded PLGA microspheres.
Yang Y; Gao Y; Mei X
Pharm Dev Technol; 2013; 18(5):1169-74. PubMed ID: 21967467
[TBL] [Abstract][Full Text] [Related]
19. Fabrication, characterization and in vitro release of paclitaxel (Taxol) loaded poly (lactic-co-glycolic acid) microspheres prepared by spray drying technique with lipid/cholesterol emulsifiers.
Mu L; Feng SS
J Control Release; 2001 Oct; 76(3):239-54. PubMed ID: 11578739
[TBL] [Abstract][Full Text] [Related]
20. Preparation, Characterization and
Tan C; Xiong S
Curr Drug Deliv; 2023; 20(10):1547-1558. PubMed ID: 36415102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
